NASDAQ
Akari Therapeutics, Plc (AKTX) has a fcf yield of -4344.99% as of Monday, August 3, 2026. This represents a 17.30% decrease compared to its 12-month average of -3704.09%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.